⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 11, 2024Frontiers in Molecular BiosciencesOpen Access

Label-free quantitative proteomic profiling reveals differential plasma protein expression in patients with obesity after treatment with liraglutide

Afshan Masood Hicham Benabdelkamel Salini Scaria Joy Abdulaziz Alhossan Bashayr Alsuwayni Ghalia N. Abdeen Madhawi Aldhwayan Nora A. Alfadda Alexander D. Miras Assim A. Alfadda

View Full Paper

Ask AI

Bookmark

Share

Abstract

Treatment and management of obesity is clinically challenging. The inclusion of GLP-1 receptor agonists (GLP1RA) in the medical management of obesity has proven to be efficacious. However, mechanisms underlying the molecular changes arising from GLP1RA treatment in patients with obesity remain to be elucidated.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Masood et al. (2024) studied this question.

synapsesocial.com/papers/68e58cceb6db643587528a49 https://doi.org/10.3389/fmolb.2024.1458675

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Metabolomic Effects of Liraglutide Therapy on the Plasma Metabolomic Profile of Patients with Obesity2024 · 4 citations
2“Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort Study2025
3GLP-1 ANALOGUES IN OBESITY THERAPY: CURRENT EVIDENCE AND FUTURE DIRECTIONS – A SYSTEMATIC REVIEW2025
4GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with ObesityBlinded Clinical Trial · 2019 · 164 citations
5794-P: Effect of Liraglutide on Abdominal Fat Distribution and Glucose Metabolism in Chinese Patients with Obesity2024